Live Breaking News & Updates on Tetravalent Immunisation

Stay updated with breaking news from Tetravalent immunisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Experimental dengue vaccine provides immunity for over four years

A dengue vaccine candidate developed by Takeda Pharmaceutical (Takeda), TAK-003, has shown promising results in a Phase 3 trial, providing continued ....

United States , Duane Gubler , Ellyana Ismail , Thomas Willemsen , Asia Pacific , Head Of Medical Affairs , Takeda Pharmaceuticals Asia Pacific , Signature Research Programme At , European Union , Takeda Pharmaceutical , Tetravalent Immunisation , Dengue Efficacy Study , Professor Duane Gubler , Emeritus Professor , Founding Director , Emerging Infectious Diseases , Signature Research Programme , Aedes Aegypti , Medical Affairs , Senior Vice President , Takeda Pharmaceuticals , Latin America ,